HÄMAGGLUTININBINDENDES PEPTID

European patent · EP3210995 · In force

Register entry

Publication number
EP3210995
Application number
EP15852879
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 23, 2015
Published
Aug 30, 2017
Granted
Mar 30, 2022
Protection ends at the latest
Oct 22, 2035
Next annual fee due
Oct 31, 2026
IPC classes
C07K 7/08 (2006.01)
A61K 38/10 (2006.01)
A61P 31/16 (2006.01)
C07K 7/64 (2006.01)
Priority
JP 2014217582 24.10.2014
PCT application
PCT/JP2015/079931 23.10.2015
PCT publication
WO2016/063969 28.04.2016
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

  5. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  6. Apr 19, 2022

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 19.04.2022

  7. Mar 30, 2022

    Granted

    Published in Swissreg on 30.03.2022

Parties

Holder

Tokyo Metropolitan Institute of Medical Science

1-6, Kamikitazawa 2-chome Setagaya-ku, Tokyo 156-8506, JP

PeptiDream Inc.

3-25-23, Tonomachi Kawasaki-ku, Kawasaki-shi, Kanagawa 210-0821, JP

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

MASUYA, Keiichi

Tokyo 153-8505, JP

KUBOTA, Kiichi

Tokyo 153-8505, JP

OHUCHI, Masaki

Tokyo 153-8505, JP

KOHARA, Michinori

Tokyo 156-8506, JP

REID, Patrick

Tokyo 153-8505, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.